Consainsights logo
Life Sciences

Oncology/Anti-cancer drugs Market

Oncology/Anti-cancer drugs Market by Therapeutic Modalities,2014-2021 (Chemotherapy, Targeted therapy, Immunotherapy (biologics therapy), Hormonal therapy, Others), by Cancer Types,2014-2021 (Blood cancer, Breast cancer, Gastrointestinal cancer, Prostate cancer, Respiratory/lung cancer, Skin cancer, Other cancers), by Countries,2014-2021 (Brazil, Argentina, Nigeria, South Africa, Iraq, Iran, Algeria, Saudi Arabia, Egypt, Other LAMEA countries), Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Oncology/Anti-cancer drugs Market from Consainsights analyses the Oncology/Anti-cancer drugs Market in the Technology & Media industry over the forecast period to 2026.

Oncology/Anti-cancer drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Oncology/Anti-cancer drugs segmentation includes Therapeutic Modalities, Cancer Types and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Therapeutic Modalities, the Oncology/Anti-cancer drugs Market analysis covers Chemotherapy, Hormonal therapy, Immunotherapy (biologics therapy), Others, Targeted therapy.

Based on the Cancer Types, the Oncology/Anti-cancer drugs Market analysis covers Blood cancer, Breast cancer, Gastrointestinal cancer, Other cancers, Prostate cancer, Respiratory/lung cancer, Skin cancer.

Key companies operating in the market include GlaxoSmithKline PLC, Sanofi, Roche Diagnostics, Amgen Inc., Merck & Company, AstraZeneca PLC., EIMC United Pharmaceuticals (EUP), Actavis plc, AbbVie Inc., Novartis AG and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Therapeutic Modalities, Cancer Types

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

GlaxoSmithKline PLC, Sanofi, Roche Diagnostics, Amgen Inc., Merck & Company, AstraZeneca PLC., EIMC United Pharmaceuticals (EUP), Actavis plc, AbbVie Inc., Novartis AG


Table of Contents

  1. Executive Summary

  2. Oncology/Anti-cancer drugs Market Overview

    1. Oncology/Anti-cancer drugs Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Oncology/Anti-cancer drugs Market 360° Synopsis: Overview
  3. Oncology/Anti-cancer drugs Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Oncology/Anti-cancer drugs Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Oncology/Anti-cancer drugs Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Oncology/Anti-cancer drugs Market: Therapeutic Modalities

    1. Introduction
    2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
    3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
    4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
    5. Others: Market Trends, Size, and Forecast (2017-2026)
    6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
  6. Oncology/Anti-cancer drugs Market: Cancer Types

    1. Introduction
    2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
    3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
    4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
    5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
    6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
    7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
    8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Oncology/Anti-cancer drugs Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. Asia-Pacific Analysis

    1. Asia-Pacific Oncology/Anti-cancer drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. China Oncology/Anti-cancer drugs Market: Cancer Types
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Japan Oncology/Anti-cancer drugs Market: Cancer Types
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. India Oncology/Anti-cancer drugs Market: Cancer Types
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Southeast Asia Oncology/Anti-cancer drugs Market: Cancer Types
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Australia & New Zealand Oncology/Anti-cancer drugs Market: Cancer Types
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Rest of Asia-Pacific Oncology/Anti-cancer drugs Market: Cancer Types
    2. Asia-Pacific Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, Y-O-Y Growth Analysis

      1. Introduction
      2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
      3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
      4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
      5. Others: Market Trends, Size, and Forecast (2017-2026)
      6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Oncology/Anti-cancer drugs Market, By Cancer Types, Y-O-Y Growth Analysis

      1. Introduction
      2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
      6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
      7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
      8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  9. Europe Analysis

    1. Europe Oncology/Anti-cancer drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Germany Oncology/Anti-cancer drugs Market: Cancer Types
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. United Kingdom Oncology/Anti-cancer drugs Market: Cancer Types
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. France Oncology/Anti-cancer drugs Market: Cancer Types
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Spain Oncology/Anti-cancer drugs Market: Cancer Types
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Russia Oncology/Anti-cancer drugs Market: Cancer Types
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Italy Oncology/Anti-cancer drugs Market: Cancer Types
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Rest of Europe Oncology/Anti-cancer drugs Market: Cancer Types
    2. Europe Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, Y-O-Y Growth Analysis

      1. Introduction
      2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
      3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
      4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
      5. Others: Market Trends, Size, and Forecast (2017-2026)
      6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Oncology/Anti-cancer drugs Market, By Cancer Types, Y-O-Y Growth Analysis

      1. Introduction
      2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
      6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
      7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
      8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  10. Middle East & Africa Analysis

    1. Middle East & Africa Oncology/Anti-cancer drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Middle East Oncology/Anti-cancer drugs Market: Cancer Types
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Africa Oncology/Anti-cancer drugs Market: Cancer Types
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Rest of Middle East & Africa Oncology/Anti-cancer drugs Market: Cancer Types
    2. Middle East & Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, Y-O-Y Growth Analysis

      1. Introduction
      2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
      3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
      4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
      5. Others: Market Trends, Size, and Forecast (2017-2026)
      6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Oncology/Anti-cancer drugs Market, By Cancer Types, Y-O-Y Growth Analysis

      1. Introduction
      2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
      6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
      7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
      8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  11. Latin America Analysis

    1. Latin America Oncology/Anti-cancer drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Brazil Oncology/Anti-cancer drugs Market: Cancer Types
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Argentina Oncology/Anti-cancer drugs Market: Cancer Types
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Mexico Oncology/Anti-cancer drugs Market: Cancer Types
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Colombia Oncology/Anti-cancer drugs Market: Cancer Types
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Rest of Latin America Oncology/Anti-cancer drugs Market: Cancer Types
    2. Latin America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, Y-O-Y Growth Analysis

      1. Introduction
      2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
      3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
      4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
      5. Others: Market Trends, Size, and Forecast (2017-2026)
      6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Oncology/Anti-cancer drugs Market, By Cancer Types, Y-O-Y Growth Analysis

      1. Introduction
      2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
      6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
      7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
      8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  12. North America Analysis

    1. North America Oncology/Anti-cancer drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. United States Oncology/Anti-cancer drugs Market: Cancer Types
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Oncology/Anti-cancer drugs Market: Therapeutic Modalities
        3. Canada Oncology/Anti-cancer drugs Market: Cancer Types
    2. North America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, Y-O-Y Growth Analysis

      1. Introduction
      2. Chemotherapy: Market Trends, Size, and Forecast (2017-2026)
      3. Hormonal therapy: Market Trends, Size, and Forecast (2017-2026)
      4. Immunotherapy (biologics therapy): Market Trends, Size, and Forecast (2017-2026)
      5. Others: Market Trends, Size, and Forecast (2017-2026)
      6. Targeted therapy: Market Trends, Size, and Forecast (2017-2026)
    3. North America Oncology/Anti-cancer drugs Market, By Cancer Types, Y-O-Y Growth Analysis

      1. Introduction
      2. Blood cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Breast cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Gastrointestinal cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Other cancers: Market Trends, Size, and Forecast (2017-2026)
      6. Prostate cancer: Market Trends, Size, and Forecast (2017-2026)
      7. Respiratory/lung cancer: Market Trends, Size, and Forecast (2017-2026)
      8. Skin cancer: Market Trends, Size, and Forecast (2017-2026)
  13. Oncology/Anti-cancer drugs Market: Company Analysis

    1. Introduction
    2. GlaxoSmithKline PLC

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Sanofi

    4. Roche Diagnostics

    5. Amgen Inc.

    6. Merck & Company

    7. AstraZeneca PLC.

    8. EIMC United Pharmaceuticals (EUP)

    9. Actavis plc

    10. AbbVie Inc.

    11. Novartis AG

  14. Oncology/Anti-cancer drugs Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Oncology/Anti-cancer drugs Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Oncology/Anti-cancer drugs Market: Structure

Figure: Global Oncology/Anti-cancer drugs Market: Value Chain Analysis

Figure: Global Oncology/Anti-cancer drugs Market: Porter's Five Forces Model

Figure: Global Oncology/Anti-cancer drugs Market: Market Dynamics

Figure: Global Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: North America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Europe Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Latin America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Global Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: North America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Europe Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Latin America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)

List of Tables

Table: Global Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2017-2026 (USD Million)

Table: North America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: United States Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Canada Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Europe Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Germany Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: United Kingdom Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: France Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Spain Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Russia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Italy Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Rest of Europe Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Asia-Pacific Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: China Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Japan Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: India Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Southeast Asia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Australia & New Zealand Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Latin America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Brazil Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Argentina Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Mexico Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Colombia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Rest of Latin America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Middle East & Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Middle East Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)

Table: Global Oncology/Anti-cancer drugs Market, By Cancer Types, 2017-2026 (USD Million)

Table: North America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: United States Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Canada Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Europe Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Germany Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: United Kingdom Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: France Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Spain Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Russia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Italy Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Rest of Europe Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Asia-Pacific Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: China Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Japan Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: India Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Southeast Asia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Australia & New Zealand Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Latin America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Brazil Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Argentina Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Mexico Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Colombia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Rest of Latin America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Middle East & Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Middle East Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)